Healthcare Global Enterprises Share Price
Healthcare Global Enterprises Share Price Today
As of 5 Jul 2026, Healthcare Global Enterprises share price is ₹655.95. The stock opened at ₹652.75, compared to its previous close of ₹649.00. During today's trading session, Healthcare Global Enterprises share price moved in the range of ₹641.15 to ₹666.45, with an average price of ₹653.80 for the day. Looking at its last 52-week, the stock has touched a low of ₹513.30 and a high of ₹804.65. On the performance front, Healthcare Global Enterprises share price has declined by 0.08% over the last six months and is up 19.62% on a year-on-year basis.
Healthcare Global Enterprises Returns Calculator
Healthcare Global Enterprises Shareholder Returns
Healthcare Global Enterprises Share Price History
| Name | Mkt Cap Cr | P/E | P/B | ROE | D/E | ROCE | Book Value | Div. Yield | Turnover | EPS(TTM) |
|---|---|---|---|---|---|---|---|---|---|---|
| Apollo Hospitals | 1,25,057.00 | 62.45 | 13.20 | 20.48% | 0.32 | 17.27% | 692.92 | 0.23% | 0.70 | 103.81 |
| Max Healthcare | 1,09,728.00 | 76.08 | 10.21 | 13.42% | 0.09 | 12.97% | 91.86 | 0.18% | 0.28 | 7.37 |
| Fortis Healthcare | 73,604.60 | 69.15 | 7.44 | 10.53% | 0.23 | 12.56% | 122.24 | 0.10% | 0.16 | 3.05 |
| Aster DM Healthcare | 40,962.60 | 95.95 | 9.69 | 8.48% | 0.31 | 10.10% | 83.23 | 0.38% | 0.46 | 5.20 |
| Narayana Hrudayalaya | 40,570.70 | 50.34 | 8.94 | 17.76% | 0.76 | 11.42% | 127.10 | 0.23% | 0.85 | 24.77 |
| Global Health | 36,176.70 | 65.28 | 9.13 | 14.05% | 0.06 | 15.26% | 149.24 | 0.04% | 0.77 | 18.46 |
| KRISHNA INST OF MED SCI L | 35,097.80 | 145.08 | 9.37 | 10.74% | 0.63 | 7.99% | 93.54 | 0.00% | 0.46 | 6.52 |
| Dr. Lal Path Labs | 27,697.10 | 54.33 | 11.04 | 20.13% | 0.07 | 25.56% | 8.90 | 1.56% | 1.01 | 30.45 |
| Syngene International | 17,755.40 | 56.03 | 3.67 | 7.76% | 0.04 | 9.67% | 116.55 | 0.28% | 0.67 | 7.58 |
| Poly Medicure | 17,614.20 | 54.92 | 5.67 | 10.37% | 0.08 | 12.71% | 301.18 | 0.20% | 0.53 | 33.15 |
Healthcare Global Enterprises Financials
Income Statement · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹2,218.14 | ₹1,907.87 | ₹1,691.41 | ₹1,394.78 |
| Other Income | ₹39.53 | ₹21.19 | ₹16.22 | ₹15.67 |
| Total Revenue | ₹2,257.66 | ₹1,929.06 | ₹1,707.63 | ₹1,410.45 |
| Total Expenses | ₹2,201.47 | ₹1,865.63 | ₹1,662.73 | ₹1,415.86 |
| Profit Before Tax | ₹56.96 | ₹67.73 | ₹44.88 | ₹87.77 |
| Tax | ₹8.13 | ₹26.40 | ₹27.25 | ₹48.85 |
| Profit After Tax | ₹48.83 | ₹41.33 | ₹17.63 | ₹38.93 |
| EPS - Basic | ₹3.19 | ₹3.46 | ₹2.11 | ₹4.14 |
| EPS - Diluted | ₹3.14 | ₹3.43 | ₹2.10 | ₹3.97 |
Cash Flow · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | ₹56.96 | ₹67.73 | ₹44.88 | ₹87.77 |
| Income before WC changes | ₹425.49 | ₹359.14 | ₹320.17 | ₹254.35 |
| Change in Assets | -₹110.54 | -₹39.69 | -₹104.21 | -₹57.50 |
| Change in Liabilities | ₹34.05 | ₹12.50 | ₹58.34 | ₹46.98 |
| Change in WC | -₹76.50 | -₹27.19 | -₹45.87 | -₹10.52 |
| Cash flow from Operations | ₹317.11 | ₹284.58 | ₹251.59 | ₹220.12 |
| Cash flow from Investing | -₹487.75 | -₹225.73 | -₹133.03 | ₹124.59 |
| Cash flow from Financing | -₹42.44 | -₹64.02 | -₹140.07 | -₹154.89 |
| Total Cash Flow | -₹213.08 | -₹5.16 | -₹21.51 | ₹189.83 |
| Cash (Start of the year) | ₹166.02 | ₹171.18 | ₹192.69 | ₹2.87 |
| Cash (End of the year) | -₹47.06 | ₹166.02 | ₹171.18 | ₹192.69 |
Balance Sheet · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹2,699.44 | ₹2,027.65 | ₹1,735.68 | ₹1,717.19 |
| Current Assets | ₹843.80 | ₹679.85 | ₹580.34 | ₹502.34 |
| Total Assets | ₹3,543.24 | ₹2,707.50 | ₹2,316.02 | ₹2,219.52 |
| Current Liabilities | ₹1,046.42 | ₹743.71 | ₹570.32 | ₹469.74 |
| Net Current Asset | -₹202.62 | -₹63.85 | ₹10.02 | ₹32.59 |
| Non-Current Liabilities | ₹1,506.77 | ₹1,098.68 | ₹876.28 | ₹866.07 |
| Equity Capital | ₹990.05 | ₹865.12 | ₹869.42 | ₹883.71 |
| Total Equity & Liabilities | ₹3,543.24 | ₹2,707.50 | ₹2,316.02 | ₹2,219.52 |
Income Statement · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹1,276.52 | ₹1,099.29 | ₹1,005.57 | ₹849.83 |
| Other Income | ₹38.58 | ₹16.88 | ₹10.82 | ₹12.42 |
| Total Revenue | ₹1,315.10 | ₹1,116.17 | ₹1,016.39 | ₹862.25 |
| Total Expenses | ₹1,260.70 | ₹1,045.21 | ₹955.77 | ₹834.12 |
| Profit Before Tax | ₹19.58 | ₹54.87 | ₹57.62 | ₹81.04 |
| Tax | ₹16.05 | ₹20.91 | ₹17.43 | ₹42.79 |
| Profit After Tax | ₹3.53 | ₹33.96 | ₹40.19 | ₹38.25 |
| EPS - Basic | ₹0.25 | ₹2.44 | ₹2.89 | ₹2.95 |
| EPS - Diluted | ₹0.25 | ₹2.42 | ₹2.88 | ₹2.83 |
Cash Flow · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | ₹19.58 | ₹53.70 | ₹57.62 | ₹81.04 |
| Income before WC changes | ₹246.15 | ₹227.52 | ₹208.12 | ₹160.13 |
| Change in Assets | -₹103.94 | ₹10.37 | -₹77.14 | -₹41.01 |
| Change in Liabilities | ₹22.30 | ₹4.12 | ₹16.67 | ₹20.00 |
| Change in WC | -₹81.64 | ₹14.49 | -₹60.47 | -₹21.02 |
| Cash flow from Operations | ₹145.95 | ₹208.89 | ₹130.40 | ₹124.40 |
| Cash flow from Investing | -₹347.32 | -₹253.94 | -₹137.70 | ₹48.65 |
| Cash flow from Financing | -₹41.55 | ₹95.92 | -₹41.71 | -₹41.04 |
| Total Cash Flow | -₹242.92 | ₹50.87 | -₹49.02 | ₹132.00 |
| Cash (Start of the year) | ₹121.18 | ₹70.31 | ₹119.33 | -₹12.68 |
| Cash (End of the year) | -₹121.75 | ₹121.18 | ₹70.31 | ₹119.33 |
Balance Sheet · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹1,963.35 | ₹1,674.82 | ₹1,357.19 | ₹1,287.46 |
| Current Assets | ₹640.45 | ₹513.07 | ₹372.52 | ₹356.16 |
| Total Assets | ₹2,603.80 | ₹2,187.89 | ₹1,729.71 | ₹1,643.62 |
| Current Liabilities | ₹622.84 | ₹373.44 | ₹220.80 | ₹215.08 |
| Net Current Asset | ₹17.61 | ₹139.63 | ₹151.72 | ₹141.07 |
| Non-Current Liabilities | ₹789.64 | ₹625.87 | ₹363.79 | ₹330.84 |
| Equity Capital | ₹1,191.32 | ₹1,188.59 | ₹1,145.12 | ₹1,097.69 |
| Total Equity & Liabilities | ₹2,603.80 | ₹2,187.89 | ₹1,729.71 | ₹1,643.62 |
About Healthcare Global Enterprises
HealthCare Global Enterprises Limited is an India-based cancer care provider. The Company offers cancer care, fertility treatment, advanced screening and diagnostic services, and tertiary care. It operates a cancer care network in India in terms of the total number of private cancer treatment centers under the brand HCG. The Company provides fertility treatment under its Milann brand. Its Milann fertility centers provide reproductive medicine services, including assisted reproduction, gynecological endoscopy and fertility preservation and follow a multidisciplinary and technology-focused approach to diagnosis and treatment. The Triesta brand offers oncology diagnostics, biomarker and translational research, and laboratory services. The Company operates a comprehensive cancer care center in Indore, Madhya Pradesh. It is also engaged in the radiation business in Indore, Madhya Pradesh. Its multispecialty hospitals deliver tertiary care for cardiac, bone and joint, brain, and spine.
Healthcare Global Enterprises Financial Highlights
- Revenue: Healthcare Global Enterprises reported revenue of ₹2,570.40 crore in FY26 vs ₹2,257.66 crore in FY25. It showed an increase of 13.85% on a yearly basis.
- Operating Profit: Healthcare Global Enterprises reported an operating profit of ₹26.92 crore in FY26 vs ₹56.96 crore in FY25. It showed a decrease of 52.74% on a year-on-year basis.
- Net Profit: Healthcare Global Enterprises reported a net profit of ₹22.78 crore in FY26 vs ₹48.83 crore in FY25. It showed a decrease of 53.35% on a yearly basis.
Healthcare Global Enterprises Quarterly Result Highlights
- Healthcare Global Enterprises reported revenue of ₹665.40 crore in Mar 2026, compared with ₹635.54 crore in Dec 2025, representing an increase of 4.70% on a quarter-on-quarter (QoQ) basis.
- Healthcare Global Enterprises reported an operating profit of ₹1.25 crore in Mar 2026, compared with ₹6.07 crore in Dec 2025, representing an increase of 120.59% on a quarter-on-quarter (QoQ) basis.
- Healthcare Global Enterprises reported a profit of ₹4.04 crore in Mar 2026, compared with ₹7.90 crore in Dec 2025, reflecting an increase of 151.14% on a QoQ basis.
- The earnings per share (EPS) of Healthcare Global Enterprises stood at ₹3.19 during Mar 2026.
Similar Stocks
FAQs on Healthcare Global Enterprises Share Price
What is Healthcare Global Enterprises share price today?
Healthcare Global Enterprises share price is ₹655.95 as on 03 Jul, 2026, 15:29 IST.
How has the Healthcare Global Enterprises share price performed in the past?
In the last 1 year, Healthcare Global Enterprises delivered a return of 19.62%. The Healthcare Global Enterprises share price hit a high of ₹804.65 and low of ₹513.30.
How much is the Mutual Fund shareholding in Healthcare Global Enterprises shares?
The Mutual Fund Shareholding in Healthcare Global Enterprises was 15.31% at the end of Mar 2026.
What is the the 52-week high and low of Healthcare Global Enterprises shares ?
The 52-week high and low of Healthcare Global Enterprises share is ₹804.65 and ₹513.30 as of 03 Jul, 2026.
What is the market cap of Healthcare Global Enterprises?
The market capitalisation of Healthcare Global Enterprises is ₹9,663.59 Crores as on 03 Jul, 2026.
What are the stock symbols of Healthcare Global Enterprises?
The stock symbol of Healthcare Global Enterprises is HCG on the NSE, 539787 on the BSE, and the ISIN is INE075I01017.
What was yesterday's closing price of Healthcare Global Enterprises shares ?
Healthcare Global Enterprises shares closed yesterday at ₹649.00 on NSE & ₹647.25 on BSE
How to buy Healthcare Global Enterprises shares?
To buy Healthcare Global Enterprises shares, open a demat account with Upstox and complete the KYC process. Once your account is set up, search for the stock and place your order.
Can I buy Healthcare Global Enterprises shares on Holidays?
No, shares of Healthcare Global Enterprises or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell Healthcare Global Enterprises shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.
What is the PE and PB ratio of Healthcare Global Enterprises?
The PE and PB ratio of Healthcare Global Enterprises is 423.04 and 7.26 respectively, as on 03 Jul, 2026, 15:29 IST.